TIME logo
Connect Wallet
Wallet Settings
Disconnect Wallet
MetaMask
WalletConnect
Sign In
My Account
Manage Account
Digital Magazines
Subscriber Benefits
TIME Storefront
Help Center
Sign Out
SUBSCRIBE FOR 99¢
Subscribe
Spotlight Story
How to Help Victims of Earthquakes in Turkey and Syria
Close
My Account
Manage Account
Digital Magazines
Subscriber Benefits
TIME Storefront
Help Center
Sign Out
Sign In
Subscribe
Sections
Home
U.S.
Politics
World
Health
Climate
Personal Finance by NextAdvisor
Future of Work by Charter
Business
Tech
Entertainment
Ideas
Science
History
Sports
Magazine
TIME 2030
TIME Studios
Video
TIME100 Talks
TIMEPieces
The TIME Vault
TIME for Health
TIME for Kids
TIME Edge
TIME CO2
Red Border: Branded Content by TIME
Join Us
Newsletters
Subscribe
Subscriber Benefits
Give a Gift
Shop the TIME Store
Connect Wallet
Customer Care
US & Canada
Global Help Center
Reach Out
Careers
Press Room
Contact the Editors
Media Kit
Reprints and Permissions
More
Privacy Policy
Your California Privacy Rights
Terms of Use
Site Map
Connect with Us
COVID-19
Stock Up on Free At-Home COVID-19 Tests While You Can
By Jamie Ducharme
The U.S. COVID-19 Public Health Emergency Ends in May. Here’s What Will Change
By Alice Park
Without Evusheld, Immunocompromised People Are on Their Own Against COVID-19
By Jamie Ducharme
Biden to End COVID-19 Emergencies May 11
By Zeke Miller and Amanda Seitz / AP
More in
COVID-19
The U.S. Still Doesn't Have Good COVID-19 Data. Here's Why That's a Problem
Data about COVID-19 hospitalizations and deaths are still incomplete. But we need them in order to start putting the pandemic behind us.
By Alice Park
January 30, 2023
COVID-19 Pandemic Will Be Over When Americans Think It Is
How will we know when the COVID-19 pandemic is over in the U.S.? Steven Phillips on how we have to think differently about risk today
By Steven Phillips
January 30, 2023
Evusheld Loses U.S. Authorization Since It's Not Effective Against New Variants
AstraZeneca's COVID-19 antibody drug, Evusheld, lost its authorization since it’s unlikely to work against current strains.
By Madison Muller/Bloomberg
January 27, 2023
FDA Experts Vote to Make All COVID-19 Vaccines and Boosters Bivalent
The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine.
By Alice Park
January 26, 2023
The Bivalent Booster Protects Against New COVID-19 Variants, New Data Show
The data add to our understanding about how well Omicron shots can protect against newer COVID-19 variants, like BQ.1.1 and XBB.1.
By Alice Park
January 25, 2023
COVID-19 Is No Longer a Public Health Emergency
It's time to rethink the data we're using to measure the severity of the COVID-19 pandemic.
By Daniel Halperin
January 25, 2023
FDA Proposes Annual COVID-19 Shots for Most Americans
This means Americans would no longer have to keep track of how many shots they’ve received or how long it’s been since their last booster.
By Matthew Perrone/AP
January 23, 2023
Moderna Says Its RSV Vaccine Works
Newly reported results from a late-stage human trial suggest Moderna's mRNA vaccine platform will work against another viral infection.
By Alice Park
January 18, 2023
China’s Lunar New Year Holiday Threatens a Grim Toll
The combination of millions of people crammed onto public transport traveling to a predominately elderly, under-vaccinated population in villages with rudimentary healthcare threatens to be a perfect storm.
By Charlie Campbell / Singapore
January 17, 2023
Hong Kong’s Leader Hopes to End Mask Mandate in 2023
The mask mandate is one of the only major curbs left remaining from the city’s COVID Zero days
By Felix Tam and Alfred Liu / Bloomberg
January 17, 2023
As COVID-19 Ravages China, Some Seek Black Market Drugs
Hong Kong customs officials seized over the weekend thousands of contraband antivirals headed for the mainland.
By Armani Syed
January 16, 2023
China’s True COVID Death Toll Estimated To Be in Hundreds of Thousands
China, which narrowed the definition of COVID mortality after it dismantled its zero tolerance approach, reported 60,000 deaths during its current outbreak.
By Bloomberg
January 16, 2023
WHO Appeals to China to Release More COVID-19 Information
“WHO requested that this type of detailed information continued to be shared with us and the public,” the agency said
By JOE McDONALD / AP
January 15, 2023
Why Rapid COVID-19 Test Results Are Getting More Confusing
At-home COVID-19 test results can be hard to interpret
By Jamie Ducharme
January 12, 2023
Satellite Images Seem to Show China’s High COVID Death Toll
Photos show increased activity at funeral homes and crematoriums, as the virus surges throughout the country and reliable data is unavailable.
By Chad de Guzman
January 12, 2023
Many Long COVID Symptoms Resolve Within a Year, Study Suggests
At least among people who had mild COVID-19.
By Jamie Ducharme
January 11, 2023
Data Doesn’t Support New COVID-19 Booster Shots for Most, Says Expert
It’s time to rethink the blanket recommendation for giving the new Omicron booster to everyone
By Alice Park
January 11, 2023
Why the U.S. Nursing Shortage Keeps Getting Worse
Nurses are pushing for better staffing at New York City hospitals amid a nationwide uptick in COVID-19 cases.
By Tara Law
January 11, 2023
China Retaliates Against S. Korea, Japan Over COVID Restrictions
The moves represent China’s first attempt at retaliation after a raft of nations recently implemented testing requirements for travelers from the country
By Bloomberg
January 10, 2023
China’s Open Borders Spark Homecoming Rush
Starting Sunday, China no longer requires quarantine for arrivals
By Bloomberg
January 8, 2023
The U.S. Keeps Offering China Its COVID Vaccines. China Keeps Saying No
China has rebuffed repeated U.S. offers to share advanced vaccines as Beijing battles a fast-spreading wave of COVID-19.
By Peter Martin and Jenny Leonard / Bloomberg
January 6, 2023
What to Know About the New XBB.1.5 Variant
Experts worry that it could start a wave of new infections and reinfections.
By Jamie Ducharme
January 3, 2023
These Countries Are Imposing COVID-19 Restrictions on China
As COVID-19 cases surge in China, more than a dozen countries have announced new restrictions.
By Yasmeen Serhan
January 2, 2023
Proxy Voting Was a Game Changer in Congress
The practice afforded some lawmakers an unprecedented level of work-life balance. House Republicans plan to ditch it once they take control.
By Mini Racker
December 27, 2022
2022: A Year In Review
Following years of uncertainty—and a global pandemic that has proven to be one of the most challenging events in history—we forged on, prepared to tackle what lay ahead. And as we continued to extract the possible from the impossible, this year taught us, above all, that our voices—no matter how big or small can change the world.
By Jenna Caldwell and Andrew D. Johnson
December 21, 2022
Dr. Anthony Fauci Is Stepping Down. Here’s His Advice For His Successor
He hopes to impart a few lessons.
By Alice Park
December 20, 2022
Why the Culture War Is Turning Back to COVID
Elon Musk said “My pronouns are Prosecute/Fauci.” Ron DeSantis is targeting COVID vaccine makers. Pandemic politics are making a comeback.
By Philip Elliott
December 19, 2022
One Million Could Die From COVID in China: Study
The country of 1.4 billion has had some of the strictest COVID containment measures in place since the pandemic began.
By Anisha Kohli
December 17, 2022
Bivalent COVID-19 Boosters Help Keep Older People Out of Hospitals, CDC Says
The bivalent boosters give adults ages 65 and older the most protection against hospitalization, according to new government data.
By Madison Muller/Bloomberg
December 16, 2022
Long COVID Has Contributed to More Than 3,500 U.S. Deaths
A new report confirms that the condition can be fatal.
By Jamie Ducharme
December 14, 2022
TIME's Best Photojournalism of 2022
The most striking, influential, and surprising photojournalism published by TIME in 2022, selected by TIME's photo editors.
By TIME Photo Department
December 13, 2022
How COVID-19 Immunity Works at This Point in the Pandemic
Vaccines, boosters, and infections can all provide immunity to COVID-19. But how do they stack up against each other?
By Alice Park
December 13, 2022
Moderna's mRNA Skin Cancer Vaccine Shows Early Promise in a New Study
The company reported encouraging results from a small study.
By Alice Park
December 13, 2022
The Case for Cautious COVID Optimism This Winter
Several key factors mean that we're unlikely to face a major COVID-19 surge this winter, argue Drs. Michael Daignault and Monica Gandhi.
By Michael Daignault and Monica Gandhi
December 13, 2022
Long COVID Isn't the Only Post-Viral Illness
Post-viral illnesses are more common than you think—but they got little attention prior to the pandemic.
By Jamie Ducharme
December 9, 2022
Why We Don't Have At-Home Testing For the Flu
Self-testing for viral illnesses like flu and RSV wasn't a necessity before the COVID-19 pandemic, but could become the norm in coming years.
By Alice Park
December 7, 2022
What China’s Zero-COVID Policy Means For Global Health
As the Chinese public’s frustrations about zero-COVID policies mount, health experts are learning about the approach's pros and cons.
By Alice Park
December 2, 2022
Microclots May Be to Blame for Long COVID Symptoms
But not all experts are convinced
By Jamie Ducharme
December 2, 2022
How China's Zero-COVID Policy Affects Climate Goals
China’s zero-COVID policy—and the subsequent outrage—have a wide range of implications, including for climate change
By Justin Worland
December 2, 2022
Why China Can’t Just Ditch Zero-COVID
Protesters in China have demanded an end to the country’s strict pandemic approach. Experts say that could invite a public health crisis.
By Chad de Guzman and Amy Gunia
December 1, 2022
COVID Protests in China Rattle Global Markets
Global stock markets and oil prices are fluctuating as the world's second-biggest economy struggles to contain rare mass protests.
By Astha Rajvanshi
November 29, 2022
Twitter Says It Stopped Policing COVID Misinformation Under Musk
The move was a part of Elon Musk’s mission to remake the social network as a place for unmoderated speech.
By Maxwell Adler/Bloomberg
November 29, 2022
Researchers Are Studying Whether Paxlovid Can Treat Long COVID
Multiple teams are studying the drug's effects on chronic Long COVID symptoms such as fatigue and brain fog.
By Jamie Ducharme
November 29, 2022
What to Know About the Zero-COVID Protests in China
Rare mass demonstrations against the country’s strict pandemic measures have broken out in multiple cities across the country, including Beijing and Shanghai.
By Chad de Guzman
November 28, 2022
Maskless World Cup Fans Pose Broadcasting Dilemma for China
Reviewed footage appears to show a state broadcaster pulling back on shots of the stadium crowds compared to other international networks.
By Low De Wei/Bloomberg
November 28, 2022
COVID-19 Is Still Upending Holiday Plans
Even as many people return to normal, some families are shaping their holiday 2022 plans around avoiding COVID-19.
By Jamie Ducharme
November 23, 2022
Load More Articles
More from
TIME
More From TIME
